Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice
Open Access
- 1 November 2005
- journal article
- extracellular mediators-and-effector-molecules
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 78 (5) , 1118-1126
- https://doi.org/10.1189/jlb.0305151
Abstract
Activated neutrophils produce serine proteases, which activate cells through protease‐activated receptor 2 (PAR2). As proteinase 3 (PR3) induces the secretion of interleukin (IL)‐18 from epithelial cells in combination with lipopolysaccharide (LPS) in vitro, we examined whether neutrophils, serine proteases, and PAR2 are involved in the induction of serum IL‐18 and IL‐18‐dependent liver injury in mice treated with heat‐killed Propionibacterium acnes and LPS. LPS‐induced serum IL‐18 levels in P. acnes‐primed mice were reduced significantly by anti‐Gr‐1 injection (depletion of neutrophils and macrophages) but not by a macrophage “suicide” technique, using liposomes encapsulating clodronate. The IL‐18 induction was decreased significantly by coadministration of a serine protease inhibitor [Nafamostat mesilate (FUT‐175)] with LPS. Serum levels of tumor necrosis factor α and liver enzymes induced by P. acnes and LPS were abolished by anti‐Gr‐1 treatment, and concomitantly, liver injury (necrotic change and granuloma formation) and Gr‐1+ cell infiltration into the liver were prevented by the treatment. A deficiency of PAR2 in mice significantly impaired IL‐18 induction by treatment with P. acnes and LPS, and only slight pathological changes in hepatic tissues occurred in the PAR2‐deficient mice treated with P. acnes and LPS. Furthermore, coadministration of exogenous murine PR3 or a synthetic PAR2 agonist (ASKH95) with LPS in the anti‐Gr‐1‐treated mice restored the serum IL‐18 levels to those in control mice treated with P. acnes and LPS. These results indicate that neutrophil recruitment and PAR2 activation by neutrophil serine proteases are critically involved in the induction of IL‐18 and IL‐18‐dependent liver injury in vivo.Keywords
Funding Information
- Scientific Research from Japan Society (15390551, 17390483)
This publication has 42 references indexed in Scilit:
- Inhibition of Enteral Enzymes by Enteroclysis with Nafamostat Mesilate Reduces Neutrophil Activation and Transfusion Requirements after Hemorrhagic ShockPublished by Wolters Kluwer Health ,2004
- Gastrointestinal functions of proteinase-activated receptorsLife Sciences, 2003
- Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory PropertiesImmunity, 2003
- Interleukin‐18 and Host Defense against InfectionThe Journal of Infectious Diseases, 2003
- Interleukin-18Journal of Leukocyte Biology, 2003
- The serine protease inhibitor antithrombin III inhibits LPS‐mediated NF‐κB activation by TLR‐4FEBS Letters, 2001
- Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.Journal of Clinical Investigation, 1998
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Induction of human TCRγδ+ and TCRγδ− CD2 + CD3 − double negative lymphocytes by bacterial stimulationInternational Immunology, 1990
- The effect of FUT-175 (nafamstat mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivoInternational Journal of Immunopharmacology, 1990